Dapoxetine
GENITO URINARY SYSTEM AND SEX HORMONES
Also known as: dapoxetine hydrochloride, LY-210448, priligy
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Dapoxetine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including SLC6A4. Recorded indications include Premature ejaculation.
- Molecular targets: SLC6A4 (1 listed in DrugCentral).
- Indications: Premature ejaculation.
- ATC code: G04BX14 (Other urologicals).
- Molecular formula: C21H23NO; molecular weight 305.42 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Premature ejaculation
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sodium-dependent serotonin transporter | SLC6A4 | inhibitor | IC50 8.95 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
G04BX14 | GENITO URINARY SYSTEM AND SEX HORMONES › UROLOGICALS › UROLOGICALS › Other urologicals |
Pharmacogenomics
Drug-label and guideline annotations from PharmGKB and CPIC.
- Swissmedic label: CYP2D6 · Actionable PGx
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Sudden hearing loss | 36.5 |
Chemical structure
| Molecular formula | C21H23NO |
|---|---|
| Molecular weight | 305.42 g/mol |
| CAS number | 119356-77-3 |
| InChIKey | USRHYDPUVLEVMC-FQEVSTJZSA-N |
| PubChem CID | 71353 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Dapoxetine used for?
DrugCentral lists the following indications for Dapoxetine: Premature ejaculation.
How does Dapoxetine work?
Its molecular targets in DrugCentral include SLC6A4 (inhibitor).
What is the chemical formula of Dapoxetine?
Dapoxetine has the molecular formula C21H23NO and a molecular weight of 305.42 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4381 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2106574 — compound record and bioactivity
- PubChem CID 71353 — chemical identifiers
- DrugBank DB04884 — drug record
- FDA UNII GB2433A4M3 — substance identity
- UniProt P31645 (SLC6A4) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
- PharmGKB / CPIC — pharmacogenomic label annotations
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.